Regeneron Pharmaceuticals (REGN) Prepaid Assets (2009 - 2026)

Regeneron Pharmaceuticals has reported Prepaid Assets for 18 years, with the latest figure at $620.9 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 32.42% year-over-year to $620.9 million; the trailing twelve-month figure through Mar 2026 stood at $620.9 million (up 32.42% YoY), and the FY2025 full-year result was $474.8 million, up 35.97% from the prior year.
• Prepaid Assets for Q1 2026 stood at $620.9 million, up from $474.8 million in the prior quarter.
• The five-year high for Prepaid Assets was $681.9 million in Q2 2024, with the low at $349.2 million in Q4 2024.
• Average Prepaid Assets over 5 years is $481.9 million, with a median of $446.4 million recorded in 2022.
• Year-over-year, Prepaid Assets surged 98.92% in 2022 and sank 37.23% in 2023.
• Tracing REGN's Prepaid Assets over 5 years: stood at $411.2 million in 2022, then slipped by 5.98% to $386.6 million in 2023, then dropped by 9.67% to $349.2 million in 2024, then soared by 35.97% to $474.8 million in 2025, then surged by 30.77% to $620.9 million in 2026.
• The last three Prepaid Assets figures came in at $620.9 million (Q1 2026), $474.8 million (Q4 2025), and $595.6 million (Q3 2025), per Business Quant data.

Peer Comparison